Abstract
Molecular diagnostics uses human saliva, tissue, blood, feces, urine, and other samples to detect disease-related markers and provides experimental diagnostic results for medical professionals in disease prevention, screening, diagnosis, stratification, prognosis, and efficacy monitoring. Affected by coronavirus disease 2019 (COVID-19), the molecular diagnosis market witnessed explosive growth in 2020. The global sales of molecular diagnosis products reached US$14.97 billion, and it is expected to reach US$32.08 billion by 2027, with a compound annual growth rate of 11.5% [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Chu D K W, Pan Y, Cheng S M S, et al. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia[J]. Clin Chem, 2020, 66(4): 549-555.
Girod, S.D., Giraud, S., Decullier, E., Lesca, G., Cottin, V., Faure, F., Merrot, O., Saurin, J.C., Cordier, J.F. and Plauchu, H. Hemorrhagic hereditary telangiectasia (Rendu-Osler Disease) and infectious diseases: an underestimated association[J]. Clin Infect Diseases, 2007, 44(6):841-845.
Feng W, Newbigging A M, Le C, et al. Molecular diagnosis of COVID-19: challenges and research needs[J]. Anal Chem, 2020, 92(15): 10196-10209.
Walter W, Pfarr N, Meggendorfer M, et al. Next-generation diagnostics for precision oncology: preanalytical considerations, technical challenges, and available technologies[C]Seminars in cancer biology. Academic Press, 2020.
Taylor C, Crosby I, Yip V, et al. A review of the important role of CYP2D6 in pharmacogenomics[J]. Genes, 2020, 11(11): 1295.
Bhutani P, Joshi G, Raja N, et al. US FDA approved drugs from 2015–June 2020: a perspective[J]. J Med Chem, 2021, 64(5): 2339-2381.
Kost G J. Molecular and point-of-care diagnostics for Ebola and new threats: National POCT policy and guidelines will stop epidemics[J]. Expert Rev Mol Diagnostics, 2018, 18(7): 657-673.
Prudent E, Raoult D. Fluorescence in situ hybridization, a complementary molecular tool for the clinical diagnosis of infectious diseases by intracellular and fastidious bacteria[J]. FEMS Microbiol Rev, 2019, 43(1): 88-107.
Haibo Song, Jiańer Yao, In vitro diagnostic industry in China[M]. Shanghai Scientific & Technical Publishers, 2020.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
Jack Shao, Qiang Li and Jie Zhang are employees of Shanghai ZJ Bio-Tech Co., Ltd.
Zhongping Deng and Xiaomei Ren are employees of Sansure Biotech Inc.
Rights and permissions
Copyright information
© 2023 Shanghai Scientific and Technical Publishers
About this chapter
Cite this chapter
Shao, J., Li, Q., Zhang, J., Deng, Z., Ren, X. (2023). Molecular Diagnostic Analyzers and Reagents. In: Song, H., Dai, L. (eds) In Vitro Diagnostic Industry in China. Springer, Singapore. https://doi.org/10.1007/978-981-99-3110-1_13
Download citation
DOI: https://doi.org/10.1007/978-981-99-3110-1_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-3109-5
Online ISBN: 978-981-99-3110-1
eBook Packages: MedicineMedicine (R0)